Skip to main content

PLEASE NOTE: For everyone’s safety, Fasken recommends anyone on-site at our Canadian offices be familiar with the COVID-19 recommendations in place which may include one or more of the following: social distancing, hand sanitizing, wearing a mask in common areas and proof of full vaccination. These measures apply to lawyers, staff, clients, service providers and other visitors.

Client Work

Purepoint Uranium closes US$4.64 million private placement

Fasken
Reading Time 1 minute read Subscribe

Overview

Client

Purepoint Uranium Group Inc.

On November 30, 2006, Purepoint Uranium Group Inc. closed a private placement with a syndicate of agents led by Blackmont Capital Inc. and including Loewen, Ondaatje, McCutcheon Limited. The placement raised gross proceeds of $4,644,360 consisting of 2,542,000 units and 4,587,000 flow-through shares. Each unit comprises one common share and one half of one common share purchase warrant, with each whole warrant entitling the holder to purchase one common share at $0.75 per share for a period of 18 months from the closing date. Purepoint is focused on the precision exploration of its seven 100% owned properties in the Canadian Athabasca Basin. Fasken Martineau advised Purepoint in this transaction with a team comprised of Bozidar Crnatovic, Wojtek Baraniak and Daye Kaba (student-at-law).

Team

    Subscribe

    Receive email updates from our team

    Subscribe